Precision therapeutics for the precision medicine era

Adam Gregory

Adam Gregory
17 May 2019

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.

Personalised medicine: patient stratification

Simon Kiddle

Simon Kiddle
29 Apr 2019

While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.

Pioneers of precision medicine

Frances Salisbury

Frances Salisbury
15 Apr 2019

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is leading.

Building an effective drug franchise: A Transatlantic perspective  -  April 23, Boston, MA

Jacqueline Murphy

Jacqueline Murphy
02 Apr 2019

It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your discoveries . In.

Dosage regimen patents: bruised but not beaten

Julie Carlisle

Julie Carlisle
28 Mar 2019

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.

Playing for time: strategies that can help extend a drug's patent life

Emily Hayes

Emily Hayes
25 Mar 2019

In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC.  Hunter explores a typical drug development timeline and suggests.

Can the EPO hold oral proceedings in Haar without infringing a party’s right to be heard?  A new referral to the Enlarged Board raises this question.

Sean Constable

Sean Constable
06 Mar 2019

The right to be heard under Article 113(1) EPC requires that parties involved in proceedings before the EPO have the right to present their arguments at.

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

Frances Salisbury

Frances Salisbury
27 Feb 2019

We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.

Is your interest legitimate? New referral to the EBOA on double patenting

Simon Kiddle

Simon Kiddle
22 Feb 2019

EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal.  The answers may force.

Plant related inventions: clarity at last?

Andrew Tindall

Andrew Tindall
06 Feb 2019

As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial prohibition at the EPO against the grant of patents for.

Fighting cancer with CAR-T therapies

Frances Salisbury

Frances Salisbury
04 Feb 2019

In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, Kymriah, to children with advanced leukaemia. This was.

Commercialising genomic research in the US: tips for obtaining patent protection

Emily Hayes

Emily Hayes
30 Jan 2019

The field of genomics has seen incredible advances over the past few decades. Technological developments coupled with decreasing costs have fuelled this.

China - a key player in the global precision medicine race

Frances Salisbury

Frances Salisbury
30 Jan 2019

With a growing economy, and a large, ageing population, China is attracting attention from global pharmaceutical and biotechnology companies. China’s home.

Eight key themes from the J.P. Morgan Healthcare Conference

Sean Jauss

Sean Jauss
14 Jan 2019

I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers attending the 37th Annual J.P. Morgan Healthcare Conference.

Precision medicine: ethics, regulation and patent law

Frances Salisbury

Frances Salisbury
13 Dec 2018

New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with greater accuracy than ever before. Indeed, due to the.

Plant related inventions: the saga continues

Frances Salisbury

Frances Salisbury
10 Dec 2018

We may be approaching the end of the year, but the saga of patents for plant related inventions at the EPO continues to develop.  The Administrative.

Patent protection: five tips for biotech start-ups

Adam Gregory

Adam Gregory
10 Dec 2018

Early-stage biotech companies are often founded based on the exciting results of pre-clinical research relating to a new product or treatment. However,.

Clovis Oncology success in European Opposition Proceedings related to Rubraca®

Richard Clegg

Richard Clegg
10 Dec 2018

Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of European Patent 2534153 in amended form covering certain.

The importance of Innovation Hubs in the UK's North West Region

Anna Mudge

Anna Mudge
02 Dec 2018

Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are often based upon truly great technology and ideas..

Supreme Court decision signals bad news for patent holders

Nick Sutcliffe

Nick Sutcliffe
14 Nov 2018

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims that.